SEC Form 4 · accession 0001127602-16-055579
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P King
Officer — President & CEO · Director
Period of report
Jun 13, 2016
Accepted (ET)
Jun 15, 2016 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2016 | M | 123,839 | $70.15 | A | 271,210 | D | |
| Common StockF2 | Jun 13, 2016 | S | 73,455 | $127.7622 | D | 197,755 | D | |
| Common StockF3 | Jun 13, 2016 | S | 45,884 | $128.7945 | D | 151,871 | D | |
| Common StockF4 | Jun 13, 2016 | S | 4,500 | $129.4724 | D | 147,371 | D | |
| Common Stock | Jun 13, 2016 | M | 72,561 | $70.15 | A | 219,932 | D | |
| Common StockF5 | Jun 13, 2016 | S | 72,561 | $127.6463 | D | 147,371 | D | |
| Common Stock | holding | — | — | — | 24,383 | I | By grantor retained annuity trust | |
| Common Stock | holding | — | — | — | 19,046 | I | By grantor retained annuity trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock OptionsF6,F7 | $70.15 | Jun 13, 2016 | M | 123,839 | D | Feb 9, 2011 | Feb 9, 2020 | Common Stock | 123,839 | 72,561 | D |
| Non-qualified Stock OptionsF6,F7 | $70.15 | Jun 13, 2016 | M | 72,561 | D | Feb 9, 2011 | Feb 9, 2020 | Common Stock | 72,561 | 0 | D |
Explanation of responses
- F1Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2The price of $127.7622 per share represents a weighted average of sales prices ranging from $127.36 to $128.35 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F3The price of $128.7945 per share represents a weighted average of sales prices ranging from $128.36 to $129.35 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F4The price of $129.4724 per share represents a weighted average of sales prices ranging from $129.36 to $129.72 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F5The price of $127.6463 per share represents a weighted average of sales prices ranging from $127.43 to $128.14 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F6Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- F7The option vested in three equal annual installments beginning on 02/09/2010 and is now fully exercisable.